Trial Details
COMPLETEDBasic Information
| Clinical ID | c648 |
|---|---|
| Identifier | NCT04567628 |
| Trial Title | Study of Relationship Between Vedolizumab Therapeutic Drug Monitoring, Biomarkers of Inflammation and Clinical Outcomes |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Inflammatory Bowel Diseases|Colitis, Ulcerative|Crohn Disease |
| Interventions | OTHER: No Intervention |
Participant Information
| Sponsor | Takeda |
|---|---|
| City | Toronto |
| Country/Region | Canada |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | - |
Time Information
| Start Date | 2020-10-05 |
|---|---|
| Primary Completion Date | 2021-09-22 |
| Completion Date | 2021-09-22 |